T lymphocyte activation in visceral adipose tissue of patients with oesophageal adenocarcinoma

British Journal of Surgery

Volumn 98, Issue 7, 2011, Pages 964-974

  Lysaght, J ^a   Allott, E H ^a   Donohoe, C L ^a   Howard, J M ^a   Pidgeon, G P ^a   Reynolds, J V ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79957787614     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7498     Document Type: Article

References (28)

1. Ryan AM, Healy LA, Power DG, Byrne M, Murphy S, Byrne PJ, et al., Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and a proinflammatory state. Ann Surg 2008; 247: 909-915. (Pubitemid 351770409)
2. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ,. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638. (Pubitemid 36459468)
3. Phillips LK, Prins JB,. The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep 2008; 10: 156-164.
4. Platell C, Cooper D, Papadimitriou JM, Hall JC,. The omentum. World J Gastroenterol 2000; 6: 169-176. (Pubitemid 30223590)
5. Litbarg NO, Gudehithlu KP, Sethupathi P, Arruda JA, Dunea G, Singh AK,. Activated omentum becomes rich in factors that promote healing and tissue regeneration. Cell Tissue Res 2007; 328: 487-497. (Pubitemid 46684496)
6. Krist LF, Koenen H, Calame W, van der Harten JJ, van der Linden JC, Eestermans IL, et al., Ontogeny of milky spots in the human greater omentum: an immunochemical study. Anat Rec 1997; 249: 399-404. (Pubitemid 27469292)
7. Shimotsuma M, Takahashi T, Kawata M, Dux K,. Cellular subsets of the milky spots in the human greater omentum. Cell Tissue Res 1991; 264: 599-601.
8. +) cells amass in human omentum and are depleted in patients with cancer and obesity. Eur J Immunol 2009; 39: 1893-1901.
9. Haffner SM,. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006; 97: 3A-11A. (Pubitemid 43139714)
10. + effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15: 914-920.
11. Ikeda H, Chamoto K, Tsuji T, Suzuki Y, Wakita D, Takeshima T, et al., The critical role of type-1 innate and acquired immunity in tumor immunotherapy. Cancer Sci 2004; 95: 697-703. (Pubitemid 39335087)
12. + T cells. J Immunol 2009; 182: 5296-5305.
13. Foster PS, Martinez-Moczygemba M, Huston DP, Corry DB,. Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease. Pharmacol Ther 2002; 94: 253-264. (Pubitemid 34756688)
14. Cottrez F, Groux H,. Regulation of TGF-beta response during T cell activation is modulated by IL-10. J Immunol 2001; 167: 773-778. (Pubitemid 32660831)
15. Ziegler SF, Ramsdell F, Alderson MR,. The activation antigen CD69. Stem Cells 1994; 12: 456-465. (Pubitemid 24278225)
16. Aktas E, Kucuksezer UC, Bilgic S, Erten G, Deniz G,. Relationship between CD107a expression and cytotoxic activity. Cell Immunol 2009; 254: 149-154.
17. + cells with different requirements for activation and differentiation. J Immunol 1991; 146: 2088-2094.
18. +) CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol Immunother 2006; 55: 1064-1071. (Pubitemid 43800721)
19. Ryan AM, Rowley SP, Fitzgerald AP, Ravi N, Reynolds JV,. Adenocarcinoma of the oesophagus and gastric cardia: male preponderance in association with obesity. Eur J Cancer 2006; 42: 1151-1158.
20. Ribeiro-Filho FF, Faria AN, Azjen S, Zanella MT, Ferreira SR,. Methods of estimation of visceral fat: advantages of ultrasonography. Obes Res 2003; 11: 1488-1494. (Pubitemid 41127333)
21. Alberti KG, Zimmet P, Shaw J,. Metabolic syndromeâa new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
22. Bulcão C, Ferreira SR, Giuffrida FM, Ribeiro-Filho FF,. The new adipose tissue and adipocytokines. Curr Diabetes Rev 2006; 2: 19-28. (Pubitemid 44096614)
23. Casten DF, Alday ES,. Omental transfer for revascularization of the extremities. Surg Gynecol Obstet 1971; 132: 301-304.
24. Rangel-Moreno J, Moyron-Quiroz JE, Carragher DM, Kusser K, Hartson L, Moquin A, et al., Omental milky spots develop in the absence of lymphoid tissue-inducer cells and support B and T cell responses to peritoneal antigens. Immunity 2009; 30: 731-743.
25. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr,. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808. (Pubitemid 38063703)
26. + T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003; 281: 65-78. (Pubitemid 37324571)
27. Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH, et al., Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res 2008; 103: 467-476.
28. Mafune K, Tanaka Y,. Influence of multimodality therapy on the cellular immunity of patients with esophageal cancer. Ann Surg Oncol 2000; 7: 609-616.